| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.34 | 3e-07 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.33 | 0.03 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.3 | 0.05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.28 | 3e-07 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.28 | 1e-07 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.27 | 3e-06 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.26 | 8e-06 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.26 | 3e-06 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.26 | 0.03 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.24 | 2e-05 |